Canada Pension Plan Investment Board’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,000
| Closed | -$123K | – | 1440 |
|
|
2024
Q2 | $123K | Sell |
3,000
-10
| -0.3% | -$411 | ﹤0.01% | 1161 |
|
|
2024
Q1 | $141K | Hold |
3,010
| – | – | ﹤0.01% | 1130 |
|
|
2023
Q4 | $144K | Hold |
3,010
| – | – | ﹤0.01% | 1037 |
|
|
2023
Q3 | $107K | Hold |
3,010
| – | – | ﹤0.01% | 957 |
|
|
2023
Q2 | $139K | Hold |
3,010
| – | – | ﹤0.01% | 949 |
|
|
2023
Q1 | $121K | Hold |
3,010
| – | – | ﹤0.01% | 999 |
|
|
2022
Q4 | $139K | Hold |
3,010
| – | – | ﹤0.01% | 1004 |
|
|
2022
Q3 | $125K | Hold |
3,010
| – | – | ﹤0.01% | 1064 |
|
|
2022
Q2 | $180K | Hold |
3,010
| – | – | ﹤0.01% | 1091 |
|
|
2022
Q1 | $219K | Sell |
3,010
-2,733
| -48% | -$199K | ﹤0.01% | 1081 |
|
|
2021
Q4 | $483K | Sell |
5,743
-5,359
| -48% | -$451K | ﹤0.01% | 1105 |
|
|
2021
Q3 | $1M | Buy |
11,102
+9,180
| +478% | +$828K | ﹤0.01% | 999 |
|
|
2021
Q2 | $183K | Buy |
1,922
+412
| +27% | +$39.2K | ﹤0.01% | 963 |
|
|
2021
Q1 | $172K | Buy |
1,510
+1,500
| +15,000% | +$171K | ﹤0.01% | 1163 |
|
|
2020
Q4 | $1K | Sell |
10
-6,100
| -100% | -$610K | ﹤0.01% | 1336 |
|
|
2020
Q3 | $502K | Sell |
6,110
-13,990
| -70% | -$1.15M | ﹤0.01% | 826 |
|
|
2020
Q2 | $1.57M | Sell |
20,100
-500
| -2% | -$39.1K | ﹤0.01% | 801 |
|
|
2020
Q1 | $915K | Hold |
20,600
| – | – | ﹤0.01% | 877 |
|
|
2019
Q4 | $880K | Buy |
20,600
+8,404
| +69% | +$359K | ﹤0.01% | 1069 |
|
|
2019
Q3 | $522K | Sell |
12,196
-6,204
| -34% | -$266K | ﹤0.01% | 1040 |
|
|
2019
Q2 | $1.17M | Buy |
+18,400
| New | +$1.17M | ﹤0.01% | 1020 |
|
|
2018
Q1 | – | Sell |
-6,300
| Closed | -$292K | – | 1277 |
|
|
2017
Q4 | $292K | Buy |
6,300
+100
| +2% | +$4.64K | ﹤0.01% | 1057 |
|
|
2017
Q3 | $330K | Buy |
+6,200
| New | +$330K | ﹤0.01% | 1017 |
|
|
2017
Q1 | – | Sell |
-5,000
| Closed | -$352K | – | 1148 |
|
|
2016
Q4 | $352K | Sell |
5,000
-1,300
| -21% | -$91.5K | ﹤0.01% | 894 |
|
|
2016
Q3 | $447K | Buy |
+6,300
| New | +$447K | ﹤0.01% | 887 |
|